2m 2m 2m 2m 2m 2m 2m
MAR LFSCI HLDG-A (MRVI)
NASDAQ
$5.27+$0.02 (+0.46%)
Price as of Jun 23, 2026 7:48 PM EDT- $774.4MMarket Cap
- 148.82%1-Year Change
- BiotechnologyIndustry
MAR LFSCI HLDG-A (MRVI)
$5.27+$0.02 (+0.46%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 185.7M -28.34% | 259.2M -10.30% | 288.9M -67.28% | 883.0M +10.48% | |
Cost of Revenue | 151.8M +0.58% | 150.9M +1.43% | 148.7M -11.96% | 169.0M +20.20% | |
Gross Profit | 34.0M -68.62% | 108.3M -22.75% | 140.2M -80.37% | 714.0M +8.41% | |
Sales and Marketing Expense | 145.1M -10.29% | 161.8M +6.86% | 151.4M +17.12% | 129.3M +29.18% | |
Research and Development Expense | -17.4M -9.46% | -19.2M +11.23% | -17.3M -5.93% | -18.4M +20.70% | |
Depreciation and Amortization Expense | 28.0M +1.53% | 27.5M +0.64% | 27.4M +12.72% | 24.3M +32.34% | |
Total Operating Expenses | 249.3M -49.63% | 494.8M +54.34% | 320.6M +3.82% | 308.8M +26.24% | |
Operating Profit | -215.3M -8.64% | -235.6M +644.49% | -31.6M -105.51% | 574.2M +3.53% | |
Interest Income | 11.4M -58.27% | 27.4M -1.17% | 27.7M +1,085.93% | 2.3M N/A | |
Interest Expense | N/A N/A | N/A N/A | -45.9M +124.81% | -20.4M -32.54% | |
Interest Income and Expense and Net | 11.4M -58.27% | 27.4M +250.86% | -18.2M +0.49% | -18.1M -40.26% | |
Total Nonoperating Income and Expense | -4.2M +77.36% | -2.3M +75.09% | -1.3M +273.46% | -358,000 -228.32% | |
Income before Taxes | -235.0M -10.14% | -261.5M -142.33% | 617.7M +12.02% | 551.5M +3.90% | |
Income Taxes | -4.2M +126.45% | -1.9M -100.25% | 756.1M +1,143.42% | 60.8M -1.15% | |
Extraordinary Items | 84.6M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -130.8M -9.72% | -144.8M +21.69% | -119.0M -154.05% | 220.2M +20.97% | |
Net Income from Continuing Operations Applicable to Common | -235.0M -10.14% | -261.5M -142.33% | 617.7M +12.02% | 551.5M +3.90% | |
Basic EPS and Net Income | -0.90 -14.29% | -1.05 +16.67% | -0.90 -153.89% | 1.67 +5.03% | |
Diluted EPS and Net Income | -0.90 -14.29% | -1.05 +16.67% | -0.90 -153.89% | 1.67 +7.05% | |
Basic Weighted Average Shares | 144.4M +4.68% | 137.9M +4.54% | 131.9M +0.28% | 131.5M +14.60% | |
Diluted Weighted Average Shares | 144.4M +4.68% | 137.9M +4.54% | 131.9M -48.33% | 255.3M -0.96% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 216.9M -32.73% | 322.4M -43.93% | 575.0M -9.04% | 632.1M +14.67% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 216.9M -32.73% | 322.4M -43.93% | 575.0M -9.04% | 632.1M +14.67% | |
Total Current Assets | 296.3M -30.97% | 429.1M -38.69% | 699.9M -17.45% | 847.9M +14.58% | |
Accumulated Depreciation | 68.1M +29.17% | 52.7M +63.62% | 32.2M +65.18% | 19.5M +55.62% | |
Property and Plant and Equipment and Net | 151.5M -7.90% | 164.5M +0.97% | 162.9M +209.14% | 52.7M +13.73% | |
Total Long-Term Assets | 41.9M -29.96% | 59.8M -22.97% | 77.6M -32.85% | 115.6M +116.25% | |
Total Assets | 770.6M -23.57% | 1.0B -32.22% | 1.5B -34.83% | 2.3B +18.98% | |
Income Taxes Payable | 742,000 -4.75% | 779,000 -22.18% | 1.0M -2.72% | 1.0M N/A | |
Total Short-Term Debt | 5.4M 0.00% | 5.4M 0.00% | 5.4M -88.59% | 47.7M +16.79% | |
Total Current Liabilities | 44.9M -21.16% | 57.0M -34.87% | 87.5M -20.59% | 110.1M +17.45% | |
Total Long-Term Debt | 286.3M -1.43% | 290.5M -44.00% | 518.7M -56.70% | 1.2B -3.24% | |
Total Long-Term Liabilities | 36.5M -30.47% | 52.5M -11.81% | 59.5M -13.75% | 69.0M +67.96% | |
Total Liabilities | 397.9M -7.70% | 431.0M -38.21% | 697.6M -49.34% | 1.4B +0.30% | |
Retained Earnings | 10.1M -92.82% | 140.9M -50.69% | 285.7M -29.41% | 404.8M +119.31% | |
Total Stockholders Equity | 212.4M -34.71% | 325.3M -21.95% | 416.8M -23.56% | 545.2M +72.81% | |
Total Shares Outstanding | 145.3M +2.36% | 142.0M -71.75% | 502.6M -1.58% | 510.7M +100.16% | |
Cash Flow | |||||
Cash from Operating Activities | -57.6M -871.24% | 7.5M -94.09% | 126.2M -76.45% | 536.0M +45.42% | |
Capital Expenditures | 13.1M -55.66% | 29.7M -54.76% | 65.6M +283.58% | 17.1M +15.08% | |
Cash from Investing Activities | -31.4M +29.15% | -24.3M -80.12% | -122.3M -54.30% | -267.6M -353.29% | |
Dividends Paid | N/A N/A | 494,000 -94.86% | 9.6M -93.60% | 150.2M -2.11% | |
Cash from Financing Activities | -16.5M -93.00% | -235.7M +285.84% | -61.1M -67.42% | -187.5M +17.89% | |
Financials Ratio | |||||
Gross Margin | 18.30% -56.21% | 41.79% -13.88% | 48.52% -40.00% | 80.87% N/A | |
Operating Margin | -115.89% +27.49% | -90.91% +729.98% | -10.95% -116.84% | 65.03% N/A | |
Return on Assets | -14.70% +26.67% | -11.61% +83.81% | -6.31% -160.23% | 10.48% N/A | |
Return on Equity | -48.64% +24.60% | -39.04% +57.76% | -24.75% -148.36% | 51.17% N/A | |
Revenue Growth | -28.34% +175.12% | -10.30% -84.69% | -67.28% -741.95% | 10.48% N/A | |
Current Ratio | 6.60 -12.44% | 7.53 -5.86% | 8.00 +3.95% | 7.70 N/A | |
Cash Ratio | 4.83 -14.67% | 5.66 -13.91% | 6.57 +14.54% | 5.74 N/A | |
Debt-to-Equity Ratio | 1.37 +51.02% | 0.91 -27.67% | 1.26 -44.95% | 2.28 N/A | |
Debt-to-Assets Ratio | 0.38 +28.99% | 0.29 -16.71% | 0.35 -35.43% | 0.55 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow